Medical News

RSS

Health reform includes changes to denied claims, health savings accounts

News outlets examine some changes to the health care system that health reform will bring, including help for those with denied insurance claims and health savings account modifications.

23 Jun 2010

iCAD image analysis software program used in DCE-MRI studies demonstrated at ASCO 2010

ACR Image MetrixTM, an imaging contract research organization with expertise in imaging trial design, techniques and data extraction, in conjunction with its software partner, iCAD, gave demonstrations of the iCAD image analysis software program used in DCE-MRI studies at the ACR Image Metrix booth during the 2010 Annual American Society of Clinical Oncology Meeting, which took place June 4-8, 2010, in Chicago, IL.

23 Jun 2010

Genentech's Lucentis for treatment of macular edema following RVO receives FDA approval

Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis® (ranibizumab injection) for the treatment of macular edema following retinal vein occlusion (RVO). The FDA approved this new indication after a six-month Priority Review.

23 Jun 2010

No increased risk of childhood cancer if born near mobile phone stations: Study

There have been concerns regarding increased risk for cancer in children born to mothers who lived near mobile phone stations during their pregnancy after a report of a cluster of childhood cancer cases near such stations. A newly published study in the British Medical Journal refutes such beliefs and has found no link to early childhood cancers and living near mobile phone masts.

22 Jun 2010

Cancer forms “intolerable burden” on the community: Health Minister

A new report reveals that here has been a 10 percent rise in cancer figures from 2006 in Australia. The figure translates to nearly 115,000 Australian cancer cases and 43,700 Australians are expected to die from the disease this year.

22 Jun 2010

Mobile, supervised drug use units considered cost effective: Report

Drug abuse experts believe Melbourne needs a mobile, supervised drug injecting van. This is mainly due to the geographical spread of drug abusers in the region.

22 Jun 2010

States worry about Medicaid funding caught in Congressional impasse

Washington Examiner: "Lawmakers in Virginia and Maryland are bracing for a congressional impasse over millions of dollars in health care funding that threatens to thrust both states into the red. The Medicaid funding is set to expire in January, and a measure to extend it is stalled in the Senate over concerns about the ballooning federal deficit.

22 Jun 2010

Nuon study confirms potential utility of tranilast as uricosuric agent

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.

22 Jun 2010

Benioff family gifts $100 million for construction of new UCSF Children's Hospital at Mission Bay

Salesforce.com chairman and CEO Marc Benioff and his family have given a $100 million private gift to help fund the construction of the new UCSF Children's Hospital at the UCSF Mission Bay campus near downtown San Francisco. The gift is both the largest gift the donors have ever made and the largest gift ever granted specifically to the UCSF Children's Hospital.

22 Jun 2010

PharmaTrust to introduce MedCentre remote pharmacy dispensing machine in UK

PharmaTrust will become the first company to introduce a remote pharmacy dispensing machine into the UK later this year. The Oakville, Ontario-based company announced yesterday at an event at Grocer's Hall in London that it is commencing trials of its MedCentre dispensing technology at five hospitals in the UK. Guests included government representatives, pharmacy stakeholders and media.

22 Jun 2010

Ricerca's Lyon facility obtains ISO 9001:2008 certification

Ricerca Biosciences, a uniquely integrated preclinical contract research drug development company providing services to the pharmaceutical industry, is pleased to announce that its Ricerca France, Lyon facility, has recently obtained the ISO 9001:2008 certification for all activities performed at the site.

22 Jun 2010

Ethicon Endo-Surgery renews research collaboration agreement with UC and Metabolic Diseases Institute

Ethicon Endo-Surgery, Inc. (EES) today announced it has renewed its research collaboration agreement with the University of Cincinnati (UC) and its Metabolic Diseases Institute (MDI). The three-year, $13.5M grant extension, is part of the EES Metabolic Applied Research Strategy (MARS), which also includes research from GI Metabolism Laboratory and Weight Center at the Massachusetts General Hospital (MGH).

22 Jun 2010

Probactive Biotech, Dalat Nuclear Research Institute enter agreement to co-develop cancer drugs

Probactive Biotech, Inc., a Garden Grove, California-based corporation, has entered into an agreement with Dalat Nuclear Research Institute to co-develop a number of cancer drugs, utilizing combinations of antitumor antibodies and antitumor radioactive compounds. Antitumor antibodies have the ability to take antitumor compounds directly to the tumor sites within the body.

22 Jun 2010

Ensemble Discovery announces name change to Ensemble Therapeutics Corporation

Ensemble Discovery today announced that it will begin operating as Ensemble Therapeutics Corporation to reflect the Company's progress and emerging pipeline by applying its macrocycle drug platform to develop novel therapeutics. The new name, Ensemble Therapeutics, conveys the company's leadership and advancement in developing novel macrocycle drug compounds that are small molecules with expanded therapeutic properties of large molecule biological drugs.

22 Jun 2010

Affymax's database lock achievement in Phase 3 Hematide trial triggers $30M milestone payment from Takeda

Affymax, Inc. today announced that it has received $30 million in development milestone payments from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™/peginesatide, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.

22 Jun 2010

Reed's signs distribution agreement with a distributor of gourmet foods and beverages based in Seoul

Reed's, Inc., maker of the top-selling sodas in natural food stores nationwide, announced today that it has reached a distribution agreement with a specialty distributor of gourmet foods and beverages based in Seoul, South Korea that will begin carrying a few Reed's handcrafted ginger ales (Original Ginger Brew and Raspberry Ginger Brew), as well as Sonoma Sparklers, for direct store delivery.

22 Jun 2010

Neurologix announces positive results from Phase 2 trial of NLX-P101 for advanced PD

Neurologix, Inc., today announced positive results in a Phase 2 trial of its investigational gene therapy for advanced Parkinson's disease, NLX-P101. Study participants who received NLX-P101 experienced statistically significant and clinically meaningful improvements in off-medication motor scores compared to control subjects who received sham surgery.

22 Jun 2010

World's first invisible-in-the-canal hearing aid launched

Starkey Laboratories, Inc., one of the world's leading hearing technology companies, is excited to introduce the S Series™ iQ OtoLens™, the world's first invisible-in-the-canal (IIC) hearing aid. OtoLens, a custom-molded hearing aid built using Starkey's Comfort Fit process, lives in the second bend of the ear, meaning that it is truly 100 percent invisible.

22 Jun 2010

WebMD completes optional redemption of 1.75% Convertible Subordinated Notes due 2023

WebMD Health Corp. has completed the optional redemption of its 1.75% Convertible Subordinated Notes due June 15, 2023. When the redemption was announced last month, approximately $188 million in aggregate principal amount of the 1.75% Notes were outstanding.

22 Jun 2010

Metabolex signs global development and license agreement with OMJPI

Metabolex, Inc. announced today that they have entered into a global development and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop and discover compounds for the treatment of type 2 diabetes and other disorders. Under the agreement, OMJPI will receive an exclusive worldwide license to develop, manufacture, and commercialize several Metabolex programs that are currently at the preclinical stage.

22 Jun 2010

Medical News

Health reform includes changes to denied claims, health savings accounts

iCAD image analysis software program used in DCE-MRI studies demonstrated at ASCO 2010

Genentech's Lucentis for treatment of macular edema following RVO receives FDA approval

No increased risk of childhood cancer if born near mobile phone stations: Study

Cancer forms “intolerable burden” on the community: Health Minister

Mobile, supervised drug use units considered cost effective: Report

States worry about Medicaid funding caught in Congressional impasse

Nuon study confirms potential utility of tranilast as uricosuric agent

Benioff family gifts $100 million for construction of new UCSF Children's Hospital at Mission Bay

PharmaTrust to introduce MedCentre remote pharmacy dispensing machine in UK

Ricerca's Lyon facility obtains ISO 9001:2008 certification

Ethicon Endo-Surgery renews research collaboration agreement with UC and Metabolic Diseases Institute

Probactive Biotech, Dalat Nuclear Research Institute enter agreement to co-develop cancer drugs

Ensemble Discovery announces name change to Ensemble Therapeutics Corporation

Affymax's database lock achievement in Phase 3 Hematide trial triggers $30M milestone payment from Takeda

Reed's signs distribution agreement with a distributor of gourmet foods and beverages based in Seoul

Neurologix announces positive results from Phase 2 trial of NLX-P101 for advanced PD

World's first invisible-in-the-canal hearing aid launched

WebMD completes optional redemption of 1.75% Convertible Subordinated Notes due 2023

Metabolex signs global development and license agreement with OMJPI

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News